한글목차

불면증 치료 시장은 2023-2028년 11억 340만 달러 규모에 달할 것으로 예상되며, 예측 기간 동안 연평균 5.72%의 CAGR로 성장할 것으로 전망됩니다.

본 보고서에서는 불면증 치료 시장의 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 불면증 유병률 증가, 진단 및 치료 기술 발전, 의료비 지출 및 보험 적용 증가에 의해 주도되고 있습니다.

이 보고서는 향후 몇 년 동안 불면증 치료 시장의 성장을 촉진할 주요 요인 중 하나로 비약물 요법에 대한 관심 증가를 꼽았습니다. 또한, 수면 모니터링 및 추적의 기술 발전과 정신건강의 중요성에 대한 인식과 수용이 증가함에 따라 시장 수요가 크게 증가할 것으로 예상됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장 전망 2023-2028년

제4장 시장 규모 실적

• 불면증 치료 세계 시장 2018-2022년
• 유형별 부문 분석 2018-2022년
• 유통 채널별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 유형별 시장 세분화

• 시장 세분화
• 비교 : 유형별
• 약제 : 시장 규모와 예측 2023-2028년
• 기기 : 시장 규모와 예측 2023-2028년
• 유형별 시장 기회

제7장 유통 채널별 시장 세분화

• 시장 세분화
• 비교 : 유통 채널별
• 처방 : 시장 규모와 예측 2023-2028년
• 시판 : 시장 규모와 예측 2023-2028년
• 유통 채널별 시장 기회

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 캐나다 : 시장 규모와 예측 2023-2028년
• 일본 : 시장 규모와 예측 2023-2028년
• 프랑스 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 지역 상황별 시장 기회

제10장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제11장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Astellas Pharma Inc.
• Aurobindo Pharma Ltd.
• Eisai Co. Ltd.
• Electromedical Products International Inc.
• Idorsia Pharmaceuticals Ltd.
• INNOVATIVE NEUROLOGICAL DEVICES LLC
• Merck and Co. Inc.
• Minerva Neurosciences Inc.
• Neurim Pharmaceuticals Ltd.
• Pfizer Inc.
• Sanofi SA
• Sumitomo Pharma Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Vanda Pharmaceuticals Inc.

제13장 부록

영문목차

The insomnia therapeutics market is forecasted to grow by USD 1103.4 mn during 2023-2028, accelerating at a CAGR of 5.72% during the forecast period. The report on the insomnia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of insomnia, technological advancements in diagnostics and treatment, and rising healthcare expenditure and insurance coverage.

Technavio's insomnia therapeutics market is segmented as below:

By Type

• Drug
• Devices

By Distribution Channel

• Prescription
• OTC

By Geographical Landscape

• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the increased focus on non-pharmacological treatments as one of the prime reasons driving the insomnia therapeutics market growth during the next few years. Also, technological advancements in sleep monitoring and tracking and growing awareness and acceptance of importance of mental health will lead to sizable demand in the market.

The report on the insomnia therapeutics market covers the following areas:

• Insomnia therapeutics market sizing
• Insomnia therapeutics market forecast
• Insomnia therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insomnia therapeutics market vendors that include Abbott Laboratories, Astellas Pharma Inc., Aurobindo Pharma Ltd., Eisai Co. Ltd., Electromedical Products International Inc., Idorsia Pharmaceuticals Ltd., INNOVATIVE NEUROLOGICAL DEVICES LLC, Mallinckrodt Plc, MEDICE Arzneimittel Putter GmbH and Co. KG, Merck and Co. Inc., Minerva Neurosciences Inc., Neurim Pharmaceuticals Ltd., Pfizer Inc., Questex LLC, Sanofi SA, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals Inc., and Viatris Inc.. Also, the insomnia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Insomnia Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Insomnia Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Drug - Market size and forecast 2023-2028
  • Chart on Drug - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drug - Market size and forecast 2023-2028 ($ million)
  • Chart on Drug - Year-over-year growth 2023-2028 (%)
  • Data Table on Drug - Year-over-year growth 2023-2028 (%)
• 6.4 Devices - Market size and forecast 2023-2028
  • Chart on Devices - Market size and forecast 2023-2028 ($ million)
  • Data Table on Devices - Market size and forecast 2023-2028 ($ million)
  • Chart on Devices - Year-over-year growth 2023-2028 (%)
  • Data Table on Devices - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 7.3 Prescription - Market size and forecast 2023-2028
  • Chart on Prescription - Market size and forecast 2023-2028 ($ million)
  • Data Table on Prescription - Market size and forecast 2023-2028 ($ million)
  • Chart on Prescription - Year-over-year growth 2023-2028 (%)
  • Data Table on Prescription - Year-over-year growth 2023-2028 (%)
• 7.4 OTC - Market size and forecast 2023-2028
  • Chart on OTC - Market size and forecast 2023-2028 ($ million)
  • Data Table on OTC - Market size and forecast 2023-2028 ($ million)
  • Chart on OTC - Year-over-year growth 2023-2028 (%)
  • Data Table on OTC - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.5 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Astellas Pharma Inc.
  • Astellas Pharma Inc. - Overview
  • Astellas Pharma Inc. - Product / Service
  • Astellas Pharma Inc. - Key offerings
• 12.4 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
• 12.5 Eisai Co. Ltd.
  • Eisai Co. Ltd. - Overview
  • Eisai Co. Ltd. - Business segments
  • Eisai Co. Ltd. - Key offerings
  • Eisai Co. Ltd. - Segment focus
• 12.6 Electromedical Products International Inc.
  • Electromedical Products International Inc. - Overview
  • Electromedical Products International Inc. - Product / Service
  • Electromedical Products International Inc. - Key offerings
• 12.7 Idorsia Pharmaceuticals Ltd.
  • Idorsia Pharmaceuticals Ltd. - Overview
  • Idorsia Pharmaceuticals Ltd. - Product / Service
  • Idorsia Pharmaceuticals Ltd. - Key offerings
• 12.8 INNOVATIVE NEUROLOGICAL DEVICES LLC
  • INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
  • INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
  • INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
• 12.9 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 12.10 Minerva Neurosciences Inc.
  • Minerva Neurosciences Inc. - Overview
  • Minerva Neurosciences Inc. - Product / Service
  • Minerva Neurosciences Inc. - Key offerings
• 12.11 Neurim Pharmaceuticals Ltd.
  • Neurim Pharmaceuticals Ltd. - Overview
  • Neurim Pharmaceuticals Ltd. - Product / Service
  • Neurim Pharmaceuticals Ltd. - Key offerings
• 12.12 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.13 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
• 12.14 Sumitomo Pharma Co. Ltd.
  • Sumitomo Pharma Co. Ltd. - Overview
  • Sumitomo Pharma Co. Ltd. - Business segments
  • Sumitomo Pharma Co. Ltd. - Key offerings
  • Sumitomo Pharma Co. Ltd. - Segment focus
• 12.15 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.16 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 Vanda Pharmaceuticals Inc.
  • Vanda Pharmaceuticals Inc. - Overview
  • Vanda Pharmaceuticals Inc. - Product / Service
  • Vanda Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations